Keywords: Vivus, Qsymia, Qnexa, USA, FDA, Weight loss, Obesity

US FDA approves second diet pill, Vivus' Qsymia

Article | 18 July 2012

Print This

In a much anticipated but largely expected decision, the US Food and Drug Administration yesterday approved Vivus’ (Nasdaq: VVUA) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in